At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
Who We Are The IMA Group is a world leader in the design and manufacture of automatic machines for processing and packaging pharmaceutical, cosmetic, food, tea and coffee products, as well as in industrial process automation. We are
Process & Computer System Validation Specialist (GCP) Philogen S.p.A., a biotech company listed on the Milan Stock Exchange and a leader in the development of innovative anti‑tumor therapies, is looking for a highly motivated and qualified Process & Computer
For a pharmaceutical company, we are looking for an ASSOCIATE SCIENTIST Requirements - Prepare formulations and perform in-process analytical characterization for development and stability studies. - Follow laboratory protocols and electronic laboratory notebook (ELN) requirements with accuracy. - Manage
This job is with GSK, an inclusive employer and a member of myGwork – the largest global platform for the LGBTQ+ business community. Please do not contact the recruiter directly. At GSK, we have bold ambitions
ASSOCIATE SCIENTIST Data: 29/08/2026 Adecco Italia For a pharmaceutical company, we are looking for an ASSOCIATE SCIENTIST Requirements Prepare formulations and perform in-process analytical characterization for development and stability studies. Follow laboratory protocols and electronic laboratory notebook (ELN) requirements
Philogen S.p.A. is seeking an Executive Assistant , a key figure who will work closely with the Board of Directors, contributing to the coordination and management of corporate activities. Who We Are Looking For We are
Additional Job Description At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and
Additional Job Description At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and